The Research and Development team at XinThera Inc. is responsible for utilizing cutting-edge computational chemistry technologies to design innovative drugs targeting critical areas in oncology and immunology. They conduct detailed research on emerging and well-validated targets, develop lead compounds, oversee preclinical studies, and translate scientific discoveries into viable therapeutic candidates. The team works collaboratively across various disciplines including chemistry, biology, and pharmacokinetics to advance the pipeline of breakthrough medicines.
View all